Esplanade Ventures
Venture capitalToronto · Pre-Seed–Series B · 11 people tracked
Investment thesis
The firm targets bold ideas in digital health that leverage AI and technology to redefine healthcare access, efficiency, and outcomes. Investment focus is on software-enabled solutions directly impacting patients or healthcare professionals, explicitly excluding invasive devices and traditional biotech. The firm leverages its team's collective 100+ years of healthcare operating and investing experience to support portfolio companies with commercialization expertise in North America.
Source: firm website, verified Aug 7, 2026.
Team · 11 people
from the firm's website & public directories
What they invest in
from 3 of 3 portfolio companiesAI & Machine Learning ×1Digital Health ×1FemTech ×1Future of Work ×1Healthtech ×1Medical Devices ×1SaaS ×1
HQs:United States×1
Investments · 3 tracked
founders shown can be your intro pathOsteoboost is an FDA-cleared, drug-free prescription device that uses precision vibration therapy to slow bone density and strength loss in postmenopausal women with osteopenia.
Digital HealthFemTechMedical Devices
Dan Burnett(Co-Founder)Michael Jaasma(Chief Scientific Officer and Co-Founder)Shane Mangrum(Co-Founder)Laura Yecies(Chief Executive Officer & President)inPamela M. Peeke(Chief Medical Officer)
Co-investorsAmbit Health VenturesBand of AngelsGolden SeedsGood Growth CapitalHealthtech CapitalNew York Angels+2 more
AHA is a chat-based tool from TheVentureCity that gives founders feedback on their startup pitch and fundraising strategy, drawing on questions investors ask and industry insights.
AI & Machine LearningFuture of WorkSaaS
Co-investorsTheVentureCityah! VenturesCorrelation VenturesKoch Disruptive TechnologiesNorwest Venture PartnersPear VC
HealthtechWest Hartford, US
Supriya Laknidhi(Executive Officer, Director)Kyle Lavin(Executive Officer, Director)
BoardElla Seitz(Director)
Co-investorsAmplify CapitalDigiTx Partners LLCFlare Capital PartnersSpringTime Ventures
Portfolio news
latest coverage across their companies
AHA · aha.org · Aug 14, 2026
Cerula Care · tipranks.com · Mar 12, 2025
Frequently asked questions
- What stage does Esplanade Ventures invest at?
- Esplanade Ventures invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does Esplanade Ventures focus on?
- Esplanade Ventures focuses on AI & Machine Learning, Biotech, Digital Health, Enterprise Software, Healthtech, Medical Devices, SaaS.
- Where is Esplanade Ventures located?
- Esplanade Ventures is headquartered in Toronto, CA.
- Does Esplanade Ventures lead rounds?
- Yes, Esplanade Ventures leads investment rounds.
Co-investors · 6
Vensana Capital is a venture capital and growth equity investment firm focused on partnering with entrepreneurs building breakthrough medical technology innovations to transform healthcare.
Distributed Ventures is an early-stage venture firm that leads Seed and Series A investments in companies innovating across the health, insurance, and wealth risk ecosystems.
Harmonix is an early-stage venture capital firm focused on advancing human health and quality of life by backing entrepreneurs and companies in healthcare, life sciences, and deep tech.
Boehringer Ingelheim Venture Fund, established in 2010, invests in biotechnology companies developing therapeutics in immuno-oncology, regenerative medicine, and gene therapy, including platform technologies and novel vaccines. The fund targets early-stage companies addressing unmet medical needs through translational research and scientific innovation.
quadraScope invests in healthcare companies developing pharmaceuticals, diagnostics, software, equipment and devices that address the biological hallmarks of aging through biological age reversal and longevity research.
Vistara Growth is a technology-focused financing firm that partners with growth-stage companies, providing capital as both a lender and an equity partner.
Firms observed investing alongside Esplanade Ventures, from public investor directories. Shared companies are the overlap with Esplanade Ventures's recorded portfolio.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.
Angel Bridge is a Japanese venture capital firm that emphasizes hands-on support as a 'supporter of entrepreneurs,' aiming to help create world-class mega ventures.